chemical entities, pharmaceutical compositions, uses of chemical entities or pharmaceutically acceptable compositions, compounds or salts thereof and methods for treating diseases, disorders or medical conditions mediated by pde1 enzyme activity and for modulating pde1 enzyme activity
Amy ALLAN,Brian DYCK,Bryan BRANSTETTER,Laurent GOMEZ,Marco PETERS,Michael I. WEINHOUSE,Tammi Jo MARRONE
申请号：
BR112014031731
公开号：
BR112014031731A2
申请日:
2013.06.18
申请国别(地区):
BR
年份:
2017
代理人:
摘要：
"Chemical entities, pharmaceutical compositions, uses of chemical entities or pharmaceutically acceptable compositions, compounds or salts thereof and methods for treating diseases, disorders or medical conditions mediated by pde1 enzyme activity and for modulating pde1 enzyme activity" summary are described herein. case compounds and chemical entities of formula I, methods for their synthesis, compositions comprising them and their use in the treatment of numerous disorders, including cognitive deficits associated with snc diseases and disorders. 1/1“entidades químicas, composições farmacêuticas, usos de entidades químicas ou de composições, compostos ou sais farmaceuticamente aceitáveis dos mesmos e métodos para tratar doenças, distúrbios ou condições médicas mediadas pela atividade enzimática pde1 e para modular a atividade da enzima pde1” resumo são descritos neste caso compostos e entidades químicas da fórmula i, métodos para a síntese dos mesmos, composições que compreendem os mesmos e o uso dos mesmos no tratamento de numerosos distúrbios, inclusive déficits cognitivos associados a doenças e distúrbios do snc. 1/1
